Max Chai

Max Chai

Trainee

Followers of Max Chai719 followers
location of Max ChaiShenyang, Liaoning, China

Connect with Max Chai to Send Message

Connect

Connect with Max Chai to Send Message

Connect
  • Timeline

  • About me

    辽宁亦度医药数据科技有限公司 - QA Manager

  • Education

    • Chiba Cancer Center

      2011 - 2013
      Master's degree Molecular Basis of Cancer NA

      • An HSP90 inhibitor, which blocks p53 degradation, suppresses adenoviruses-mediated p53 production and the apoptosis, Kuan Chai, Tagawa Masatoshi, Japanese Cancer Association, 2013• Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells, Liu Y, Liu JH, Chai K, Tashiro S, Onodera S, Ikejima T, J Pharm Pharmacol, 65(11), 2013• CD90 is a diagnostic marker to differentiate between malignant pleural… Show more • An HSP90 inhibitor, which blocks p53 degradation, suppresses adenoviruses-mediated p53 production and the apoptosis, Kuan Chai, Tagawa Masatoshi, Japanese Cancer Association, 2013• Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells, Liu Y, Liu JH, Chai K, Tashiro S, Onodera S, Ikejima T, J Pharm Pharmacol, 65(11), 2013• CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry, Kawamura K, Hiroshima K, Suzuki T, Chai K, Yamaguchi N, Shingyoji M, Yusa T, Tada Y, Takiguchi Y, Tatsumi K, Shimada H, Tagawa M, Am J Clin Pathol, 140(4), 2013• E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents, Yamanaka M, Tada Y, Kawamura K, Li Q, Okamoto S, Chai K, , Takiguchi Y, Tatsumi K, Tagawa M, J Thorac Oncol, 7(12), 2012 Show less

    • 千葉大学

      2011 - 2013
      Master's degree Pharmaceutical Science GPA: 3.8/4

      Activities and Societies: 参加千叶大学空手道部 参加千叶大学留学生会 兼职汉语教师兼职助教千叶大学生物化学创新课程负责人,讲师。

    • Shenyang Pharmaceutical University

      2007 - 2011
      Bachelor of Engineering (B.E.) Pharmaceutical Engineering 50/250

      Activities and Societies: 跆拳道协会-创始人, 会长 爱心社-外联部部长 07级制药工程学院期队长 跆拳道协会会长:一年内达成协会人数0至100,成为学校内唯一五星级协会。期队长:女生节活动中获得最绅士期队称号,健美操大赛第二名,服装设计大赛第二名等。

  • Experience

    • Chiba Cancer Center

      Aug 2011 - Oct 2013
      Trainee

      Trainee in Department of Cell Therapy

    • Quintiles

      Feb 2014 - Jun 2015
      CRA

      Using metrics and ad-hoc reports to increase efficiency of SDV.Developing VBA in excel help site with drug accountability.Being professional and helpful to build up relationship with sites.Supporting junior CRA co-monitoring to gain trust from site.Led team achievingLPI ONE MONTH prior to projected time.

    • 精鼎医药

      Jul 2015 - Dec 2019

      Study Team Lead for CDA team,Managing all aspects of data process from CRF design till post DB lock analysis.Proactively interact with all functions even external users such as site staffs, improving first time quality and shortening data cleaning cycle time.

      • Senior Quality Specialist

        Nov 2018 - Dec 2019
      • Quality Specialist

        Oct 2017 - Oct 2018
      • Clinical Data Analyst

        Jul 2015 - Nov 2017
    • 辽宁亦度医药数据科技有限公司

      Jan 2020 - now
      Quality Assurance Manager
  • Licenses & Certifications

    • GCP Expert